Progression of prostate carcinogenesis and dietary methyl donors: Temporal dependence

Shabana Shabbeer, Simon A. Williams, Brian W. Simons, James G. Herman, Michael A Carducci

Research output: Contribution to journalArticle

Abstract

Insufficient dose of dietary methyl groups are associated with a host of conditions ranging from neural tube defects to cancer.Onthe other hand, it is not certain what effect excess dietary methyl groups could have on cancer. This is especially true for prostate cancer, a disease that is characterized by increasing DNA methylation changes with increasing grade of the cancer. In this three-part study in animals, we look at (i) the effect of excess methyl donors on the growth rate of prostate cancer in vivo, (ii) the ability of 5-aza-2′- deoxycytidine (AdC), a demethylating agent, to demethylate in the presence of excess dietary methyl donors, and (iii) the effect of in utero feeding of excess methyl donors to the later onset of prostate cancer. The results show that when mice are fed a dietary excess of methyl donors, we do not see (i) an increase in the growth rate of DU-145 and PC-3 xenografts in vivo, or (ii) interference in the ability of AdC to demethylate the promoters of androgen receptor or Reprimo of prostate cancer xenografts but (iii) a protective effect on the development of higher grades of prostate cancer in the "Hi-myc" mouse model of prostate cancer which were fed the increased methyl donors in utero. We conclude that the impact of dietary methyl donors on prostate cancer progression depends upon the timing of exposure to the dietary agents. When fed before the onset of cancer, that is, in utero, excess methyl donors can have a protective effect on the progression of cancer.

Original languageEnglish (US)
Pages (from-to)229-239
Number of pages11
JournalCancer Prevention Research
Volume5
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Prostate
Prostatic Neoplasms
Carcinogenesis
decitabine
Neoplasms
Heterografts
Deoxycytidine
Neural Tube Defects
Androgen Receptors
DNA Methylation
Growth
Hand

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Progression of prostate carcinogenesis and dietary methyl donors : Temporal dependence. / Shabbeer, Shabana; Williams, Simon A.; Simons, Brian W.; Herman, James G.; Carducci, Michael A.

In: Cancer Prevention Research, Vol. 5, No. 2, 02.2012, p. 229-239.

Research output: Contribution to journalArticle

Shabbeer, Shabana ; Williams, Simon A. ; Simons, Brian W. ; Herman, James G. ; Carducci, Michael A. / Progression of prostate carcinogenesis and dietary methyl donors : Temporal dependence. In: Cancer Prevention Research. 2012 ; Vol. 5, No. 2. pp. 229-239.
@article{fdc3f75ec579497c88840a50abdee05e,
title = "Progression of prostate carcinogenesis and dietary methyl donors: Temporal dependence",
abstract = "Insufficient dose of dietary methyl groups are associated with a host of conditions ranging from neural tube defects to cancer.Onthe other hand, it is not certain what effect excess dietary methyl groups could have on cancer. This is especially true for prostate cancer, a disease that is characterized by increasing DNA methylation changes with increasing grade of the cancer. In this three-part study in animals, we look at (i) the effect of excess methyl donors on the growth rate of prostate cancer in vivo, (ii) the ability of 5-aza-2′- deoxycytidine (AdC), a demethylating agent, to demethylate in the presence of excess dietary methyl donors, and (iii) the effect of in utero feeding of excess methyl donors to the later onset of prostate cancer. The results show that when mice are fed a dietary excess of methyl donors, we do not see (i) an increase in the growth rate of DU-145 and PC-3 xenografts in vivo, or (ii) interference in the ability of AdC to demethylate the promoters of androgen receptor or Reprimo of prostate cancer xenografts but (iii) a protective effect on the development of higher grades of prostate cancer in the {"}Hi-myc{"} mouse model of prostate cancer which were fed the increased methyl donors in utero. We conclude that the impact of dietary methyl donors on prostate cancer progression depends upon the timing of exposure to the dietary agents. When fed before the onset of cancer, that is, in utero, excess methyl donors can have a protective effect on the progression of cancer.",
author = "Shabana Shabbeer and Williams, {Simon A.} and Simons, {Brian W.} and Herman, {James G.} and Carducci, {Michael A}",
year = "2012",
month = "2",
doi = "10.1158/1940-6207.CAPR-11-0357",
language = "English (US)",
volume = "5",
pages = "229--239",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Progression of prostate carcinogenesis and dietary methyl donors

T2 - Temporal dependence

AU - Shabbeer, Shabana

AU - Williams, Simon A.

AU - Simons, Brian W.

AU - Herman, James G.

AU - Carducci, Michael A

PY - 2012/2

Y1 - 2012/2

N2 - Insufficient dose of dietary methyl groups are associated with a host of conditions ranging from neural tube defects to cancer.Onthe other hand, it is not certain what effect excess dietary methyl groups could have on cancer. This is especially true for prostate cancer, a disease that is characterized by increasing DNA methylation changes with increasing grade of the cancer. In this three-part study in animals, we look at (i) the effect of excess methyl donors on the growth rate of prostate cancer in vivo, (ii) the ability of 5-aza-2′- deoxycytidine (AdC), a demethylating agent, to demethylate in the presence of excess dietary methyl donors, and (iii) the effect of in utero feeding of excess methyl donors to the later onset of prostate cancer. The results show that when mice are fed a dietary excess of methyl donors, we do not see (i) an increase in the growth rate of DU-145 and PC-3 xenografts in vivo, or (ii) interference in the ability of AdC to demethylate the promoters of androgen receptor or Reprimo of prostate cancer xenografts but (iii) a protective effect on the development of higher grades of prostate cancer in the "Hi-myc" mouse model of prostate cancer which were fed the increased methyl donors in utero. We conclude that the impact of dietary methyl donors on prostate cancer progression depends upon the timing of exposure to the dietary agents. When fed before the onset of cancer, that is, in utero, excess methyl donors can have a protective effect on the progression of cancer.

AB - Insufficient dose of dietary methyl groups are associated with a host of conditions ranging from neural tube defects to cancer.Onthe other hand, it is not certain what effect excess dietary methyl groups could have on cancer. This is especially true for prostate cancer, a disease that is characterized by increasing DNA methylation changes with increasing grade of the cancer. In this three-part study in animals, we look at (i) the effect of excess methyl donors on the growth rate of prostate cancer in vivo, (ii) the ability of 5-aza-2′- deoxycytidine (AdC), a demethylating agent, to demethylate in the presence of excess dietary methyl donors, and (iii) the effect of in utero feeding of excess methyl donors to the later onset of prostate cancer. The results show that when mice are fed a dietary excess of methyl donors, we do not see (i) an increase in the growth rate of DU-145 and PC-3 xenografts in vivo, or (ii) interference in the ability of AdC to demethylate the promoters of androgen receptor or Reprimo of prostate cancer xenografts but (iii) a protective effect on the development of higher grades of prostate cancer in the "Hi-myc" mouse model of prostate cancer which were fed the increased methyl donors in utero. We conclude that the impact of dietary methyl donors on prostate cancer progression depends upon the timing of exposure to the dietary agents. When fed before the onset of cancer, that is, in utero, excess methyl donors can have a protective effect on the progression of cancer.

UR - http://www.scopus.com/inward/record.url?scp=84863403004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863403004&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-11-0357

DO - 10.1158/1940-6207.CAPR-11-0357

M3 - Article

C2 - 22139053

AN - SCOPUS:84863403004

VL - 5

SP - 229

EP - 239

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 2

ER -